{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:25:22Z","timestamp":1786991122920,"version":"build-2736575974"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81371414"],"award-info":[{"award-number":["81371414"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81473577"],"award-info":[{"award-number":["81473577"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003398","name":"Shanxi Scholarship Council of China","doi-asserted-by":"publisher","award":["2014-7"],"award-info":[{"award-number":["2014-7"]}],"id":[{"id":"10.13039\/501100003398","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.intimp.2018.09.041","type":"journal-article","created":{"date-parts":[[2018,11,13]],"date-time":"2018-11-13T12:55:52Z","timestamp":1542113752000},"page":"69-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Protective and therapeutic role of Bilobalide in cuprizone-induced demyelination"],"prefix":"10.1016","volume":"66","author":[{"given":"Ruo-Xuan","family":"Sui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Juan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Wen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3335-8992","authenticated-orcid":false,"given":"Bao-Guo","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cun-Gen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.intimp.2018.09.041_bb0005","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/WCO.0b013e328346056f","article-title":"Multiple sclerosis as a neurodegenerative disease: pathology, mechanisms and therapeutic implications","volume":"2011","author":"Stadelmann","year":"2011","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.intimp.2018.09.041_bb0010","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.it.2012.09.007","article-title":"Communication between pathogenic T cells and myeloid cells in neuroinflammatory disease","volume":"34","author":"Codarri","year":"2013","journal-title":"Trends Immunol."},{"key":"10.1016\/j.intimp.2018.09.041_bb0015","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/jnc.13242","article-title":"Microglial Hv1 proton channel promotes cuprizone-induced demyelination through oxidative damage","volume":"135","author":"Liu","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.intimp.2018.09.041_bb0020","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00401-009-0591-3","article-title":"The cuprizone animal model: new insights into an old story","volume":"118","author":"Kipp","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.intimp.2018.09.041_bb0025","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1365-2990.2011.01165.x","article-title":"Intravenous administration of human ES-derived neural precursor cells attenuates cuprizone-induced CNS demyelination","volume":"37","author":"Crocker","year":"2011","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.intimp.2018.09.041_bb0030","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12974-017-0923-5","article-title":"Protective and therapeutic role of 2-carba-cyclic phosphatidic acid in demyelinating disease","volume":"14","author":"Yamamoto","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.intimp.2018.09.041_bb0035","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/j.1532-5415.2000.tb02589.x","article-title":"The efficacy of ginkgo for elderly people with dementia and age-associated memory impairment: new results of a randomized clinical trial","volume":"48","author":"van Dongen","year":"2000","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.intimp.2018.09.041_bb0040","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1007\/s00018-003-3080-1","article-title":"Neuroprotective effects of Ginkgo biloba extract","volume":"60","author":"Ahlemeyer","year":"2003","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.intimp.2018.09.041_bb0045","first-page":"45","article-title":"Bilobalide, a constituent of Ginkgo biloba L., potentiates drug-metabolizing enzyme activities in mice: possible mechanism for anticonvulsant activity against 4-O-methylpyridoxine-induced convulsions","volume":"96","author":"Sasaki","year":"1997","journal-title":"Res. Commun. Mol. Pathol. Pharmacol."},{"key":"10.1016\/j.intimp.2018.09.041_bb0050","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1043-6618(02)00233-5","article-title":"Bilobalide and neuroprotection","volume":"46","author":"Defeudis","year":"2002","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.intimp.2018.09.041_bb0055","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.brainres.2013.07.003","article-title":"Neurodegeneration after transient brain ischemia in aged mice: beneficial effects of bilobalide","volume":"1529","author":"Schwarzkopf","year":"2013","journal-title":"Brain Res."},{"key":"10.1016\/j.intimp.2018.09.041_bb0060","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/FBP.0b013e32836360ab","article-title":"Bilobalide, a unique constituent of Ginkgo biloba, inhibits inflammatory pain in rats","volume":"24","author":"Goldie","year":"2013","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.intimp.2018.09.041_bb0065","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.neuroscience.2006.08.037","article-title":"Bilobalide prevents ischemia-induced edema formation in vitro and in vivo","volume":"144","author":"Mdzinarishvili","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.intimp.2018.09.041_bb0070","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/S0022-3565(24)39323-1","article-title":"Reactive oxygen species-induced apoptosis in PC12 cells and protective effect of bilobalide","volume":"293","author":"Zhou","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.intimp.2018.09.041_bb0075","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1055\/s-2006-959686","article-title":"Regeneration of motor nerves in bilobalide-treated rats","volume":"59","author":"Bruno","year":"1993","journal-title":"Planta Med."},{"key":"10.1016\/j.intimp.2018.09.041_bb0080","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pbb.2013.03.005","article-title":"Protective effects of bilobalide on Abeta (25\u201335) induced learning and memory impairments in male rats","volume":"106","author":"Yin","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.intimp.2018.09.041_bb0085","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.brainres.2011.10.005","article-title":"Neuroprotective effects of bilobalide are accompanied by a reduction of ischemia-induced glutamate release in vivo","volume":"1425","author":"Lang","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.intimp.2018.09.041_bb0090","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3233\/JAD-2009-1189","article-title":"Stimulation of neurogenesis and synaptogenesis by bilobalide and quercetin via common final pathway in hippocampal neurons","volume":"18","author":"Tchantchou","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.intimp.2018.09.041_bb0095","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13578-017-0181-3","article-title":"Strain differences in cuprizone induced demyelination","volume":"7","author":"Yu","year":"2017","journal-title":"Cell Biosci."},{"key":"10.1016\/j.intimp.2018.09.041_bb0100","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4196\/kjpp.2018.22.2.183","article-title":"Berberine alleviates symptoms of anxiety by enhancing dopamine expression in rats with post-traumatic stress disorder","volume":"22","author":"Lee","year":"2018","journal-title":"Korean J. Physiol. Pharmacol."},{"issue":"2018","key":"10.1016\/j.intimp.2018.09.041_bb0105","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3389\/fnbeh.2018.00029","article-title":"Anxiolytic effect of exogenous ketone supplementation is abolished by adenosine A1 receptor inhibition in Wistar albino Glaxo\/Rijswijk rats","volume":"12","author":"Kovacs","year":"2018","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.intimp.2018.09.041_bb0110","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ntt.2013.06.002","article-title":"Short-term atrazine exposure causes behavioral deficits and disrupts monoaminergic systems in male C57BL\/6 mice","volume":"39","author":"Lin","year":"2013","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.intimp.2018.09.041_bb0115","first-page":"613","article-title":"Electroacupuncture promotes remyelination after Cuprizone treatment by enhancing myelin debris clearance","volume":"10","author":"Zhu","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.intimp.2018.09.041_bb0120","first-page":"507","article-title":"Progesterone enhanced remyelination in the mouse Corpus callosum after cuprizone induced demyelination","volume":"40","author":"Kashani","year":"2015","journal-title":"Iran J. Med. Sci."},{"key":"10.1016\/j.intimp.2018.09.041_bb0125","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.it.2010.06.006","article-title":"B cells and autoantibodies: complex roles in CNS injury","volume":"31","author":"Ankeny","year":"2010","journal-title":"Trends Immunol."},{"key":"10.1016\/j.intimp.2018.09.041_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011769","article-title":"Effects of fumaric acids on cuprizone induced central nervous system de- and remyelination in the mouse","volume":"5","author":"Moharregh-Khiabani","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2018.09.041_bb0135","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nrn3053","article-title":"Repertoire of microglial and macrophage responses after spinal cord injury","volume":"12","author":"David","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.intimp.2018.09.041_bb0140","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.bbi.2012.06.008","article-title":"Neuroinflammation after traumatic brain injury: opportunities for therapeutic intervention","volume":"26","author":"Kumar","year":"2012","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.intimp.2018.09.041_bb0145","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1002\/anie.200300601","article-title":"Chemistry and biology of terpene trilactones from Ginkgo biloba","volume":"43","author":"Stromgaard","year":"2004","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.intimp.2018.09.041_bb0150","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12974-014-0167-6","article-title":"Neuroprotective effects of bilobalide on cerebral ischemia and reperfusion injury are associated with inhibition of pro-inflammatory mediator production and down-regulation of JNK1\/2 and p38 MAPK activation","volume":"11","author":"Jiang","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.intimp.2018.09.041_bb0155","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.immuni.2017.02.015","article-title":"Brain ischemia suppresses immunity in the periphery and brain via different neurogenic innervations","volume":"46","author":"Liu","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2018.09.041_bb0160","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.4049\/jimmunol.176.11.6523","article-title":"Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages","volume":"176","author":"Offner","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2018.09.041_bb0165","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s11481-012-9406-8","article-title":"A transient decrease in spleen size following stroke corresponds to splenocyte release into systemic circulation","volume":"7","author":"Seifert","year":"2012","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.intimp.2018.09.041_bb0170","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00001756-200402090-00029","article-title":"Lateralization in autonomic dysfunction in ischemic stroke involving the insular cortex","volume":"15","author":"Meyer","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.intimp.2018.09.041_bb0175","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.expneurol.2009.03.044","article-title":"Blockade of adrenoreceptors inhibits the splenic response to stroke","volume":"218","author":"Ajmo","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.intimp.2018.09.041_bb0180","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/S0002-9440(10)61247-3","article-title":"Massive apoptosis in lymphoid organs in animal models for primary and secondary progressive multiple sclerosis","volume":"167","author":"Tsunoda","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.intimp.2018.09.041_bb0185","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/0006-8993(87)90499-9","article-title":"Blood-brain barrier permeability to horseradish peroxidase in twitcher and cuprizone-intoxicated mice","volume":"425","author":"Kondo","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/j.intimp.2018.09.041_bb0190","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s40478-017-0497-6","article-title":"Blood-brain barrier hyperpermeability precedes demyelination in the cuprizone model","volume":"5","author":"Berghoff","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.intimp.2018.09.041_bb0195","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrneurol.2012.98","article-title":"The immunology of acute stroke","volume":"8","author":"Chamorro","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.intimp.2018.09.041_bb0200","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.4049\/jimmunol.1102808","article-title":"Long-lived bone marrow plasma cells are induced early in response to T cell-independent or T cell-dependent antigens","volume":"188","author":"Bortnick","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2018.09.041_bb0205","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/35011084","article-title":"A receptor for phosphatidylserine-specific clearance of apoptotic cells","volume":"405","author":"Fadok","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2018.09.041_bb0210","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1084\/jem.188.2.387","article-title":"Systemic exposure to irradiated apoptotic cells induces autoantibody production","volume":"188","author":"Mevorach","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2018.09.041_bb0215","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1046\/j.1471-4159.1997.69010214.x","article-title":"Demyelinating antibodies to myelin oligodendrocyte glycoprotein and galactocerebroside induce degradation of myelin basic protein in isolated human myelin","volume":"69","author":"Menon","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.intimp.2018.09.041_bb0220","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jaut.2017.09.002","article-title":"Myelin oligodendrocyte glycoprotein-specific antibodies from multiple sclerosis patients exacerbate disease in a humanized mouse model","volume":"86","author":"Khare","year":"2018","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.intimp.2018.09.041_bb0225","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1007\/s10067-017-3724-4","article-title":"Autoantibodies against myelin sheath and S100beta are associated with cognitive dysfunction in patients with rheumatoid arthritis","volume":"36","author":"Baptista","year":"2017","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.intimp.2018.09.041_bb0230","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.braindev.2017.05.004","article-title":"Clinical features in very early-onset demyelinating disease with anti-MOG antibody","volume":"39","author":"Nishiyama","year":"2017","journal-title":"Brain Dev."},{"key":"10.1016\/j.intimp.2018.09.041_bb0235","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1177\/1352458515622986","article-title":"Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in \u2018pattern II multiple sclerosis\u2019 and brain biopsy findings in a MOG-IgG-positive case","volume":"22","author":"Jarius","year":"2016","journal-title":"Mult. Scler."},{"key":"10.1016\/j.intimp.2018.09.041_bb0240","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12974-017-0984-5","article-title":"Human antibodies against the myelin oligodendrocyte glycoprotein can cause complement-dependent demyelination","volume":"14","author":"Peschl","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.intimp.2018.09.041_bb0245","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1474-4422(15)00313-0","article-title":"The search for the target antigens of multiple sclerosis, part 2: CD8+ T cells, B cells, and antibodies in the focus of reverse-translational research","volume":"15","author":"Hohlfeld","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.intimp.2018.09.041_bb0250","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2249.1992.tb03042.x","article-title":"Autostimulatory effects of IL-6 on excessive B cell differentiation in patients with systemic lupus erythematosus: analysis of IL-6 production and IL-6R expression","volume":"88","author":"Kitani","year":"1992","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.intimp.2018.09.041_bb0255","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/ni.3153","article-title":"IL-6 as a keystone cytokine in health and disease","volume":"16","author":"Hunter","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2018.09.041_bb0260","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/0166-2236(96)10049-7","article-title":"Microglia: a sensor for pathological events in the CNS","volume":"19","author":"Kreutzberg","year":"1996","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.intimp.2018.09.041_bb0265","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1523\/JNEUROSCI.2456-15.2016","article-title":"Neurodegeneration triggers peripheral immune cell recruitment into the forebrain","volume":"36","author":"Scheld","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.intimp.2018.09.041_bb0270","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s12192-016-0728-y","article-title":"Ginkgolides and bilobalide protect BV2 microglia cells against OGD\/reoxygenation injury by inhibiting TLR2\/4 signaling pathways","volume":"21","author":"Zhou","year":"2016","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.intimp.2018.09.041_bb0275","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12974-014-0167-6","article-title":"Neuroprotective effects of bilobalide on cerebral ischemia and reperfusion injury are associated with inhibition of pro-inflammatory mediator production and down-regulation of JNK1\/2 and p38 MAPK activation","volume":"11","author":"Jiang","year":"2014","journal-title":"J. Neuroinflammation"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918307471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918307471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:07:31Z","timestamp":1761584851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576918307471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":55,"alternative-id":["S1567576918307471"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2018.09.041","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective and therapeutic role of Bilobalide in cuprizone-induced demyelination","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2018.09.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}